Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intra-abdominal Infection (cIAI) and”

17 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 17 results

Testing effectiveness (Phase 2)Looking for participantsNCT06794541
What this trial is testing

Evaluate the Safety and Tolerability of Eravacycline in Pediatric Patients Aged 8 to 17 With Complicated Intra-abdominal Infections (cIAI)

Who this might be right for
Complicated Intra-abdominal Infections (cIAI)
Tetraphase Pharmaceuticals, Inc 35
Large-scale testing (Phase 3)Study completedNCT01445678
What this trial is testing

Study Comparing the Safety and Efficacy of Intravenous CXA-201 and Intravenous Meropenem in Complicated Intraabdominal Infections

Who this might be right for
Complicated Intra-abdominal Infection
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 494
Not applicableStudy completedNCT01096511
What this trial is testing

Moxifloxacin i.v. in the Treatment of Complicated Intra-Abdominal Infection (cIAI)

Who this might be right for
Secondary PeritonitisAbscess, Intra-Abdominal
Bayer 1,001
Testing effectiveness (Phase 2)Study completedNCT06086626
What this trial is testing

Assess the Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Neonates and Infants

Who this might be right for
Gram-Negative Bacterial Infections
Shionogi 30
Not applicableStudy completedNCT02364284
What this trial is testing

Reporting Patterns and Results of Initial Antibiotic Treatment in Patients With cUTI, cIAI,NP Including VAP

Who this might be right for
Urinary Tract Infection (cUTI)Intra-abdominal Infection (cIAI) andNosocomial Pneumonia (NP)
Pfizer 1,322
Testing effectiveness (Phase 2)Study completedNCT04335539
What this trial is testing

Assess the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of Cefiderocol in Hospitalized Pediatric Participants

Who this might be right for
Gram-negative Bacterial InfectionsBloodstream Infections (BSI)Complicated Intra-abdominal Infection (cIAI)+4 more
Shionogi 53
Testing effectiveness (Phase 2)Study completedNCT00488345
What this trial is testing

Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability of Tigecycline in Patients 8 to 11 Years of Age

Who this might be right for
Bacterial InfectionsIntra-Abdominal InfectionPneumonia, Bacterial+2 more
Wyeth is now a wholly owned subsidiary of Pfizer 59
Large-scale testing (Phase 3)Looking for participantsNCT07089186
What this trial is testing

Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in Carbapenem-Resistant Enterobacteriaceae Infections

Who this might be right for
Hospital-acquired Bacterial Pneumonia (HABP)Ventilator-associated Bacterial Pneumonia (VABP)Complicated Intra-abdominal Infection (cIAI)+2 more
Qilu Pharmaceutical Co., Ltd. 80
Not applicableStudy completedNCT00827541
What this trial is testing

Post-Authorization Study Evaluating Safety Of Tigecycline

Who this might be right for
Intra-Abdominal InfectionsSkin Disease, InfectiousSoft Tissues Infections
Pfizer 115
Large-scale testing (Phase 3)Study completedNCT01499290
What this trial is testing

Compare Ceftazidime-Avibactam + Metronidazole Versus Meropenem for Hospitalized Adults With Complicated Intra-Abdominal Infections

Who this might be right for
Complicated Intra-Abdominal Infection
Pfizer 493
Testing effectiveness (Phase 2)Ended earlyNCT03354754
What this trial is testing

LYS228 PK, Clinical Response, Safety and Tolerability in Patients With Complicated Intra-abdominal Infection (cIAI)

Who this might be right for
Intra-abdominal Infections
Novartis Pharmaceuticals 3
Large-scale testing (Phase 3)Study completedNCT03293485
What this trial is testing

Efficacy and Safety of Imipenem+Cilastatin/Relebactam (MK-7655A) in Japanese Participants With Complicated Intra-abdominal Infection or Complicated Urinary Tract Infection (MK-7655A-017)

Who this might be right for
Complicated Intra-abdominal InfectionComplicated Urinary Tract Infection
Merck Sharp & Dohme LLC 83
Large-scale testing (Phase 3)Not Yet RecruitingNCT06633718
What this trial is testing

Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in CIAI

Who this might be right for
Intra-abdominal Infections
Qilu Pharmaceutical Co., Ltd. 786
Post-approval studies (Phase 4)Study completedNCT00230971
What this trial is testing

Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection (cIAI)

Who this might be right for
AppendicitisCholecystitisDiverticulitis+3 more
Wyeth is now a wholly owned subsidiary of Pfizer 473
Post-approval studies (Phase 4)Study completedNCT00488306
What this trial is testing

Study Evaluating the Safety and Efficacy of Tigecycline in Hospitalized Patients With cIAI

Who this might be right for
Abdominal Abscess
Wyeth is now a wholly owned subsidiary of Pfizer 50
Testing effectiveness (Phase 2)Study completedNCT01506271
What this trial is testing

Study of the Safety, Tolerability, and Efficacy of Relebactam (MK-7655) + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone to Treat Complicated Intra-Abdominal Infection [cIAI] (MK-7655-004)

Who this might be right for
Intra-abdominal Infections
Merck Sharp & Dohme LLC 351
Testing effectiveness (Phase 2)Study completedNCT03217136
What this trial is testing

MK-7625A Plus Metronidazole Versus Meropenem in Pediatric Participants With Complicated Intra-Abdominal Infection (cIAI) (MK-7625A-035)

Who this might be right for
Complicated Intra-Abdominal Infection
Merck Sharp & Dohme LLC 94